Prospective Randomized Controlled trial of low dose long term Peg-Interferon alpha-2a treatment after curative ablation for Hepatocellular Carcinoma
Not Applicable
- Conditions
- Chronic hepatitis C Hepatocellular carcinoma
- Registration Number
- JPRN-C000000323
- Lead Sponsor
- Department of Gastroenterology University of Tokyo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Not provided
Exclusion Criteria
Patient with 1.Drug allergy against Interferon. 2.Allergy against biological drugs. 3.Poorly controlled heart disease. 4.Extrahepatic metastasis of HCC 5.Active cancer of other organ. 6.Severe renal dysfunction; BUN>30mg/dL, or Cre>2.0mg/dL 7.on the herb treatment 8.other chronic liver disease like AIH or hepatitisB 9.Depression 10.on other clinical trial 11. any reason which medical doctor regard the patient as unsuitable for this test.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. HCC recurent rate 2. Time to recurrence
- Secondary Outcome Measures
Name Time Method